Review of various molecular targets on mast cells and its relation to obesity: A future perspective

Souravh Bais1, Reena Kumari1, Yash Prashar1

  • 1Department of Pharmacology, Rayat Institute of Pharmacy, Railmajra, SBS Nagar District, Punjab 144506, India.

Insights

This review explores molecular targets to suppress mast cell overexpression in obesity. Understanding mast cell roles in metabolic diseases offers new therapeutic avenues.

Area of Science:

  • Immunology
  • Metabolic Diseases
  • Cell Biology

Background:

  • Mast cells are key players in allergic and immunological diseases.
  • Their role in metabolic diseases, including obesity, is increasingly recognized.
  • Overexpression of mast cells contributes to disease pathology.

Purpose of the Study:

  • To review the literature on mast cells and obesity.
  • To identify molecular targets for suppressing mast cell activity in obesity.
  • To explore the connection between mast cells and metabolic diseases.

Main Methods:

  • Comprehensive literature search of databases (PubMed, Scopus, Web of Science, Google Scholar) over the last 20 years.
  • Keywords used: "Mast Cell", "obesity", "role of mast cell or role in obesity".
  • Review and selection of 87 relevant publications from 827 initial articles.

Main Results:

  • Mast cells exhibit diverse characteristics relevant to obesity.
  • Several molecular targets have been identified for mast cell suppression.
  • Evidence links mast cell activity to various metabolic dysfunctions in obesity.

Conclusions:

  • Mast cells are significant contributors to obesity and related metabolic disorders.
  • Targeting mast cells presents a potential therapeutic strategy for obesity.
  • Further research is warranted to elucidate specific molecular pathways and therapeutic interventions.

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.0K
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
3.0K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
18.1K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
322
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.5K